Disclosure: WIIP is our brand. NMN Boost is mentioned in this article as a product we selected and developed. It is evaluated alongside the same evidence applied to NMN supplementation in general.
This article is for informational purposes only and does not constitute medical advice. NMN supplements do not treat, cure, or prevent any disease. Consult your healthcare provider before starting any new supplement.
NMN Side Effects — The Short Answer
Across published human clinical trials at doses from 250mg to 1,250mg daily, NMN has been consistently well tolerated, with no serious adverse events attributed to supplementation. The most rigorous safety study to date gave healthy adults 1,250mg daily for four weeks and found no clinically significant changes in liver enzymes, kidney function, or blood chemistry (Fukamizu et al., 2022). That said, "well tolerated in trials" is not the same as "side-effect-free for everyone." Mild digestive discomfort, headaches, and occasional sleep disruption have been reported anecdotally, and there are specific groups — pregnant women, people undergoing cancer treatment, and anyone on prescription medication — who should talk to a doctor first. This article walks through what the actual trial data shows, dose by dose.
What the Clinical Trials Report About Adverse Events
Marketing pages tend to say "no side effects." The honest version is: the published trials recorded adverse events systematically, and here is what they found.
Irie et al. (2020) — Single doses up to 500mg
The first human NMN study gave 10 healthy Japanese men single oral doses of 100mg, 250mg, and 500mg. No significant clinical symptoms were observed, and heart rate, blood pressure, oxygen saturation, and body temperature stayed within normal ranges at all doses (Irie et al., 2020).
Kim et al. (2022) — 250mg daily for 12 weeks
In 108 older Japanese adults (65+), 12 weeks of 250mg NMN daily produced no reported adverse events. This is particularly relevant if you are considering NMN for an older family member, as this trial enrolled exactly that demographic (Kim et al., 2022).
Yi et al. (2023) — 300mg, 600mg and 900mg daily for 60 days
This dose-ranging trial in 80 middle-aged adults recorded adverse events across placebo, 300mg, 600mg, and 900mg groups. The events that did occur were mild, distributed across all groups including placebo, and none were attributed to NMN. Blood safety markers remained normal at every dose (Yi et al., 2023).
Fukamizu et al. (2022) — 1,250mg daily for 4 weeks
The highest-dose safety study published to date. Thirty-one healthy adults took 1,250mg daily — roughly 2.5 times the typical maintenance dose — for four weeks. No serious adverse events occurred, and liver enzymes, kidney markers, and body composition showed no clinically significant changes (Fukamizu et al., 2022).
Safety Summary Table
| Study | Dose | Duration | Adverse events attributed to NMN |
|---|---|---|---|
| Irie et al., 2020 | 100–500mg (single dose) | Single dose | None observed |
| Kim et al., 2022 | 250mg | 12 weeks | None reported |
| Yi et al., 2023 | 300–900mg | 60 days | None attributed; mild events similar to placebo |
| Fukamizu et al., 2022 | 1,250mg | 4 weeks | No serious events; blood markers normal |
A 2023 review in Advances in Nutrition covering the full body of human NMN trials reached the same conclusion: doses up to 1,200mg daily have been administered without serious safety signals (Song et al., 2023).
Mild Side Effects People Actually Report
Outside the controlled trial setting, some users report mild effects — usually in the first week or two. These are anecdotal, not trial-documented, but they come up often enough to be worth knowing about.
Digestive discomfort or nausea
The most commonly reported issue, usually associated with taking NMN on an empty stomach at doses of 500mg or above. Taking your dose with breakfast typically resolves it. Starting at 250mg rather than 500mg also reduces the chance of this happening.
Headaches
Occasionally reported in the first days of use. Staying hydrated and taking NMN with food usually helps. If headaches persist beyond the first two weeks, stop and consult your doctor — persistent symptoms should never be pushed through.
Sleep disruption
NMN supports NAD+ production, which is involved in cellular energy metabolism. Some users who take NMN in the evening report feeling too alert at bedtime. The simple fix: take it in the morning. Morning dosing also matches the protocol used in most clinical trials.
What about flushing?
Flushing — the hot, red-face reaction — is a well-known side effect of high-dose niacin (vitamin B3 in its nicotinic acid form). NMN is a different molecule and does not activate the same receptor pathway, so niacin-style flushing is not an expected effect of NMN and has not been reported in the clinical trials.
Who Should Talk to a Doctor Before Taking NMN
The trial safety data above comes from generally healthy adults. It does not automatically extend to everyone.
- Pregnant or breastfeeding women. There is no human safety data for NMN in pregnancy or lactation. The absence of data means the default answer is: do not take it during this period.
- People undergoing cancer treatment. NAD+ metabolism overlaps with pathways relevant to some cancers and chemotherapy agents. This is an area of active research, and anyone with a cancer diagnosis should not take NMN without explicit clearance from their oncologist.
- People on prescription medication. No harmful interactions have been documented in trials, but NMN affects NAD+ pathways used in liver metabolism. If you take immunosuppressants, chemotherapy agents, or medications with narrow dosing windows, check with your pharmacist or doctor first.
- People with liver or kidney conditions. The reassuring liver and kidney data comes from healthy participants. If you have an existing condition, your specialist should make the call.
- Children and teenagers. All published trials enrolled adults. NMN is an adult supplement.
The Honest Limitations of the Safety Data
Two things the marketing rarely mentions, which we think NZ buyers deserve to know.
First, trial durations are short. The longest published human NMN trials run 12 weeks. There is no multi-year human safety dataset yet. Australia's TGA reflects this caution: it has approved NMN as a supplement ingredient with a maximum recommended dose of 500mg per day and a recommended use period of 12 weeks for listed products (NutraIngredients, Dec 2025). If you plan to take NMN continuously beyond that, periodic check-ins with your healthcare provider are the sensible approach.
Second, dose does not scale benefits indefinitely. The Yi et al. (2023) data shows benefits plateau around 600mg daily. Taking more than that increases cost, and pushes beyond the doses with the deepest safety record, without evidence of additional benefit. More is not better with NMN — 250–500mg daily is where the evidence sits.
How to Minimise the Chance of Side Effects
- Start at 250mg daily for the first two to four weeks before moving to 500mg. This is the protocol supported by the Kim (2022) and Igarashi (2022) trials.
- Take it in the morning, with food if you notice any stomach discomfort.
- Buy products that state their exact dose per capsule and avoid proprietary blends, so you always know precisely how much NMN you are taking.
- Stop and consult a doctor if you experience anything persistent or concerning. Supplements should never require pushing through symptoms.
Frequently Asked Questions
Is NMN safe to take long term?
The honest answer: the published human data covers up to 12 weeks of continuous use, and within that window NMN was well tolerated at doses up to 1,250mg daily. Long-term use beyond 12 weeks is based on extrapolation. Australia's TGA recommends a 12-week use period for listed products, and periodic check-ins with your healthcare provider are sensible if you take NMN continuously.
Does NMN cause insomnia?
Not in the clinical trials — in fact, the Kim et al. (2022) trial found reduced daytime drowsiness in older adults. Anecdotally, some users feel more alert if they take NMN in the evening. Morning dosing avoids this entirely.
Can NMN damage your liver or kidneys?
The published trials show the opposite of a warning signal: liver enzymes and kidney markers stayed within normal ranges even at 1,250mg daily for four weeks (Fukamizu et al., 2022). However, those participants were healthy adults. If you have an existing liver or kidney condition, consult your specialist before taking NMN.
Does NMN interact with medications?
No harmful interactions have been documented in published trials, but NMN affects NAD+ metabolism, which overlaps with pathways used by some chemotherapy agents, immunosuppressants, and liver-metabolised drugs. If you take prescription medication, a quick conversation with your pharmacist is the right move.
Why did the US FDA restrict NMN if it is safe?
The US situation is a regulatory classification dispute, not a safety finding. The FDA's position relates to NMN being studied as a pharmaceutical ingredient, which affects whether it can be sold as a dietary supplement in the US market. No regulator, including the FDA, has flagged a safety problem with NMN at supplement doses. In New Zealand, NMN is legally sold as a dietary supplement, and Australia's TGA formally approved it as a supplement ingredient in late 2025.
How WIIP NMN Boost Approaches Safety
We designed WIIP NMN Boost around the safety framework in this article. Each capsule contains exactly 250mg of NMN — the evidence-based starting dose — so you can start low and step up to the 500mg maintenance dose (two capsules) only when you know how you respond. The label states the exact dose per capsule. No proprietary blends, no hidden ingredients, no therapeutic claims.
NZ-made and clinician-developed, with the dosing aligned to the published trial protocols rather than marketing-driven megadoses.
View WIIP NMN Boost — $94.99, 60 Capsules (250mg each), 500mg Per Two-Capsule Serve
Related Reading
- NMN Dosage Guide: How Much Should You Take? — Dose-by-dose breakdown of the clinical trial data
- NMN Supplement NZ: Complete Buyer's Guide — Purity, regulation, and what to look for when buying NMN in New Zealand
- What Is NMN? The Complete New Zealand Guide — The fundamentals of NMN and NAD+
Sources
- Irie, J. et al. (2020). "Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men." Endocrine Journal. PubMed: 31685720
- Kim, M. et al. (2022). "Effect of 12-Week Intake of Nicotinamide Mononucleotide on Sleep Quality, Fatigue, and Physical Performance in Older Japanese Adults: A Randomized, Double-Blind Placebo-Controlled Study." Nutrients. PMC8877443
- Yi, L. et al. (2023). "The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial." GeroScience. DOI
- Fukamizu, Y. et al. (2022). "Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women." Scientific Reports. DOI
- Song, Q. et al. (2023). "The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update." Advances in Nutrition. PMC10721522
- NutraIngredients (Dec 2025). "Australia's TGA approves NMN ingredient for supplement use." Link
Dr. Jun is a Senior Chiropractor at Auckland Wellness Centre with 12 years of clinical experience. He holds qualifications from the New Zealand College of Chiropractic (NZCC) and is certified in Titleist Performance Institute (TPI) assessment and Active Release Techniques (ART). Dr. Jun selected and developed WIIP supplements based on clinical experience and published research, with a focus on evidence-based dosing and transparent labelling.
This article is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any new supplement. NMN supplements are not intended to treat, cure, or prevent any disease.